Swinkels J A, de Jonghe F
University of Amsterdam Department of Psychiatry, The Netherlands.
Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:19-25. doi: 10.1097/00004850-199501004-00003.
There are a number of criteria that can be used when selecting an antidepressant. In particular safety criteria are important, and a distinction can be drawn between "safe" and "less safe" antidepressants. The relative safety of different antidepressants has been assessed by looking at answers to the questions: how safe is the drug in overdose; how dangerous are its side effects at therapeutic dose; and does it have any dangerous interactions with other drugs or substances? Based on current data it can be said with reasonable confidence that fluvoxamine, fluoxetine, paroxetine and moclobemide are "safe" antidepressants, and mianserin and trazodone are also "safe" but to a lesser extent (mainly because of hypnosedation). In conclusion, "safe" antidepressants should be considered as the first choice in the treatment of depression.
在选择抗抑郁药时可采用多种标准。特别是安全性标准很重要,并且可以区分“安全”和“不太安全”的抗抑郁药。通过审视以下问题的答案来评估不同抗抑郁药的相对安全性:药物过量时有多安全;治疗剂量下其副作用有多危险;以及它与其他药物或物质是否存在危险的相互作用?根据目前的数据,可以有合理的把握说氟伏沙明、氟西汀、帕罗西汀和吗氯贝胺是“安全”的抗抑郁药,米安色林和曲唑酮也是“安全”的,但程度稍低(主要是因为有催眠作用)。总之,“安全”的抗抑郁药应被视为治疗抑郁症的首选。